Abiopharma

🔍 Reed Michael (Director)

Company: USA TODAY Co., Inc. (TDAY)

Report Date: 2026-08-11

Detailed Transactions and Holdings:

• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-11 | Code: H | shares_owned_after: 3,170,931.00
• Acquired 383,771 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-11 | Code: A | equity_swap_involved: 0 | shares_owned_after: 383,771.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
• Holds 113,379 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-11 | Code: H | shares_owned_after: 113,379.00 | Footnotes: F1, F3, F3
• Holds 239,808 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-11 | Code: H | shares_owned_after: 239,808.00 | Footnotes: F1, F4, F4

Footnotes:

• F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
• F2: The RSUs were granted under the Issuer's 2023 Stock Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vest one-third on the first, second, and third anniversary of the date of grant.
• F3: One-third of the original grant of these RSUs vested on August 6, 2025 and one-third vested on August 6, 2026, and except as otherwise provided in the award notice, the remaining one-third will vest on the third anniversary of the date of grant.
• F4: One-third of the original grant of these RSUs vested on August 5, 2026, and except as otherwise provided in the award notice, one-third will vest on each of the second and third anniversary of the date of grant.